FS DEVELOPMENT CORP. : Regulation FD Disclosure (form 8-K)

Item 7.01. Regulation FD Disclosure.

On February 5, 2021, Gemini Therapeutics, Inc. (f/k/a FS Development Corp.), a Delaware corporation (the "Company"), completed the transactions contemplated by the Merger Agreement, dated as of October 15, 2020, among the Company, FSG Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company ("Merger Sub"), Gemini Therapeutics Sub, Inc., a Delaware corporation ("Old Gemini"), and Shareholder Representative Services LLC, pursuant to which Merger Sub merged with and into Old Gemini, with Old Gemini surviving the merger as a wholly-owned subsidiary of the Company.

                                       1

© Edgar Online, source Glimpses